{"id":"W2055127103","doi":"10.3816/clml.2010.n.015","title":"Bortezomib as a Treatment Option in Patients With Waldenström Macroglobulinemia","year":2010,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bortezomib; Medicine; Rituximab; Waldenstrom macroglobulinemia; Macroglobulinemia; Internal medicine; Oncology; Proteasome inhibitor; Multiple myeloma; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001067051,0.001744261,0.006523709,0.0006915354,0.0001587703,0.0001426703,0.0008946485,0.003318448,0.0003806083],"category_scores_gemma":[0.001263433,0.001194004,0.00185374,0.001276864,0.0009345125,0.0001913498,0.0004133661,0.001891177,0.002736389],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.08171739,"about_ca_system_score_gemma":0.07426788,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008594824,"about_ca_topic_score_gemma":0.0001959356,"domain_scores_codex":[0.9896373,0.0006085114,0.003800079,0.002522215,0.001666374,0.001765511],"domain_scores_gemma":[0.9924098,0.001589442,0.001185855,0.002924467,0.0004595456,0.001430867],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001597911,0.001290521,0.001582707,0.003401815,0.0005873687,0.002627498,0.00002896428,0.000001009717,1.3775e-7,0.00008919866,0.0003894682,0.9884034],"study_design_scores_gemma":[0.05166053,0.003991934,0.03192471,0.01392355,0.002248261,0.001282734,0.000009638135,0.0001701037,0.00000260636,0.0000392691,0.8935719,0.001174725],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1748077,0.81148,0.000007086577,0.00007799891,0.001124027,0.007366879,0.000172654,0.0003387065,0.004625016],"genre_scores_gemma":[0.002525604,0.9875618,0.001284234,0.0002655223,0.001500917,0.0007568251,0.001947029,0.0004415221,0.003716545],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9872287,"threshold_uncertainty_score":0.9995303,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0433455937624061,"score_gpt":0.3944574783435849,"score_spread":0.3511118845811788,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}